Vid Matišić

1.7k total citations · 2 hit papers
27 papers, 1.0k citations indexed

About

Vid Matišić is a scholar working on Rheumatology, Infectious Diseases and Genetics. According to data from OpenAlex, Vid Matišić has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 7 papers in Infectious Diseases and 7 papers in Genetics. Recurrent topics in Vid Matišić's work include Osteoarthritis Treatment and Mechanisms (7 papers), Mesenchymal stem cell research (6 papers) and COVID-19 Clinical Research Studies (6 papers). Vid Matišić is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Mesenchymal stem cell research (6 papers) and COVID-19 Clinical Research Studies (6 papers). Vid Matišić collaborates with scholars based in Croatia, United States and Bosnia and Herzegovina. Vid Matišić's co-authors include Dragan Primorac, Vilim Molnar, Željko Jeleč, Igor Borić, Damir Hudetz, Trpimir Vrdoljak, Eduard Rod, Fabijan Čukelj, Roko Bjelica and Dinko Vidović and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Viruses.

In The Last Decade

Vid Matišić

24 papers receiving 1.0k citations

Hit Papers

Cytokines and Chemokines Involved in Osteoarthritis Patho... 2020 2026 2022 2024 2021 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vid Matišić Croatia 11 547 240 191 184 112 27 1.0k
Vilim Molnar Croatia 11 552 1.0× 249 1.0× 197 1.0× 198 1.1× 112 1.0× 32 1.1k
Paolo Dolzani Italy 21 493 0.9× 175 0.7× 157 0.8× 109 0.6× 73 0.7× 53 1.0k
A. van Caam Netherlands 18 687 1.3× 595 2.5× 206 1.1× 197 1.1× 83 0.7× 45 1.4k
Chuanlong Wu China 22 208 0.4× 580 2.4× 73 0.4× 463 2.5× 64 0.6× 38 1.5k
J Gatterová Czechia 18 1.2k 2.2× 187 0.8× 512 2.7× 336 1.8× 29 0.3× 37 1.5k
Melissa Cantley Australia 20 268 0.5× 570 2.4× 60 0.3× 116 0.6× 37 0.3× 33 1.2k
Fiona E. Watt United Kingdom 22 792 1.4× 188 0.8× 266 1.4× 354 1.9× 44 0.4× 65 1.4k
Dinko Vidović Croatia 13 325 0.6× 164 0.7× 113 0.6× 434 2.4× 38 0.3× 35 962
Yohei Yamamoto Japan 17 167 0.3× 393 1.6× 75 0.4× 156 0.8× 102 0.9× 67 986
Jia Yuan China 22 137 0.3× 675 2.8× 36 0.2× 140 0.8× 191 1.7× 47 1.5k

Countries citing papers authored by Vid Matišić

Since Specialization
Citations

This map shows the geographic impact of Vid Matišić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vid Matišić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vid Matišić more than expected).

Fields of papers citing papers by Vid Matišić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vid Matišić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vid Matišić. The network helps show where Vid Matišić may publish in the future.

Co-authorship network of co-authors of Vid Matišić

This figure shows the co-authorship network connecting the top 25 collaborators of Vid Matišić. A scholar is included among the top collaborators of Vid Matišić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vid Matišić. Vid Matišić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brlek, Petar, Leo Mršić, Mateo Sokač, et al.. (2025). Exploring the Pharmacogenomic Map of Croatia: PGx Clustering of 522-Patient Cohort Based on UMAP + HDBSCAN Algorithm. International Journal of Molecular Sciences. 26(2). 589–589.
2.
Matišić, Vid, et al.. (2023). Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency. International Journal of Molecular Sciences. 24(17). 13498–13498. 3 indexed citations
3.
Primorac, Dragan, et al.. (2023). Importance of Cellular Immunity and IFN-γ Concentration in Preventing SARS-CoV-2 Infection and Reinfection: A Cohort Study. Viruses. 15(3). 792–792. 3 indexed citations
4.
Molnar, Vilim, Željko Jeleč, Petar Brlek, et al.. (2022). Results of Treating Mild to Moderate Knee Osteoarthritis with Autologous Conditioned Adipose Tissue and Leukocyte-Poor Platelet-Rich Plasma. Journal of Personalized Medicine. 13(1). 47–47. 3 indexed citations
5.
Molnar, Vilim, Vid Matišić, Roko Bjelica, et al.. (2022). Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. Genes. 13(6). 949–949. 49 indexed citations
6.
Primorac, Dragan, Petar Brlek, Vid Matišić, et al.. (2022). Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination. Vaccines. 10(3). 442–442. 21 indexed citations
7.
Polančec, Denis, Damir Hudetz, Željko Jeleč, et al.. (2022). Medicinal signaling cells niche in stromal vascular fraction from lipoaspirate and microfragmented counterpart. Croatian Medical Journal. 63(3). 265–272. 5 indexed citations
8.
Bjelica, Roko, et al.. (2022). Mesenchymal Stem Cells Based Treatment in Dental Medicine: A Narrative Review. International Journal of Molecular Sciences. 23(3). 1662–1662. 32 indexed citations
9.
Matišić, Vid, Petar Brlek, Vilim Molnar, et al.. (2022). Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study. Croatian Medical Journal. 63(3). 257–264. 5 indexed citations
10.
Primorac, Dragan, Lenart Girandon, Ariana Barlič, et al.. (2021). Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report. Croatian Medical Journal. 62(3).
11.
Polančec, Denis, Damir Hudetz, Željko Jeleč, et al.. (2021). Polychromatic Flow Cytometric Analysis of Stromal Vascular Fraction from Lipoaspirate and Microfragmented Counterparts Reveals Sex-Related Immunophenotype Differences. Genes. 12(12). 1999–1999. 9 indexed citations
12.
Brlek, Petar, Darko Antičević, Vilim Molnar, et al.. (2021). X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in PLS3. Genes. 12(12). 1851–1851. 11 indexed citations
13.
Primorac, Dragan, Vid Matišić, Vilim Molnar, et al.. (2021). Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics. 13(9). 1481–1481. 3 indexed citations
14.
Šikić, Jozica, et al.. (2021). COVID-19: The Impact on Cardiovascular System. Biomedicines. 9(11). 1691–1691. 7 indexed citations
15.
Primorac, Dragan, Lenart Girandon, Ariana Barlič, et al.. (2021). Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report. Croatian Medical Journal. 62(3). 288–296. 10 indexed citations
16.
Primorac, Dragan, Vilim Molnar, Vid Matišić, et al.. (2021). Comprehensive Review of Knee Osteoarthritis Pharmacological Treatment and the Latest Professional Societies’ Guidelines. Pharmaceuticals. 14(3). 205–205. 74 indexed citations
17.
Molnar, Vilim, Vid Matišić, Ivan Kodvanj, et al.. (2021). Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis. International Journal of Molecular Sciences. 22(17). 9208–9208. 382 indexed citations breakdown →
18.
Primorac, Dragan, Lidija Bach‐Rojecky, Vid Matišić, et al.. (2020). Pharmacogenomics at the Center of Precision Medicine: Challenges and Perspective in an Era of Big Data. Pharmacogenomics. 21(2). 141–156. 30 indexed citations
19.
Primorac, Dragan, Vilim Molnar, Eduard Rod, et al.. (2020). Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations. Genes. 11(8). 854–854. 278 indexed citations breakdown →
20.
Matišić, Vid, et al.. (2019). Dasatinib-induced nephrotic syndrome: a case of phenoconversion?. Croatian Medical Journal. 60(3). 250–254. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026